PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

首次发布于 2004 年 2 月 16 日

Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

计划入组 25 人 · 首次发布于 2004 年 6 月 11 日

Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors

计划入组 123 人 · 首次发布于 2016 年 2 月 10 日

Lanreotide(Somatuline)

C₅₄H₆₉N₁₁O₁₀S₂ · Rx

solid tumors therapy

anti-mesothelin + anti-CD40 CAR T-cell therapy (metastatic solid tumors)

Crinetics

United States

CNS Pharmaceuticals

United States

Iovance Biotherapeutics

United States

MimiVax and Roswell Park Launch Phase 2 Trial of SurVaxM Cancer Vaccine for Metastatic Neuroendocrine Tumors

Lutetium Lu 177 Dotatate Shows Promise in Metastatic Bronchopulmonary Neuroendocrine Tumors

Nanopharmaceutics Completes Phase II Enrollment for Triapine Combination Therapy in Neuroendocrine Tumors